C. Le Péchoux

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

Arnaud Scherpereel, Philippe Astoul, Thierry Berghmans et al. · European Respiratory Journal · 2009 · 636 citations · Full text

Medicine, Oncology, Surgery +17

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 570 citations · Full text

Medicine, Oncology, Radiation Oncology +15

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 503 citations · Full text

Medicine, Oncology, Radiation Oncology +13

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Johan Vansteenkiste, Lucio Crinò, Christophe Dooms et al. · Annals of Oncology · 2014 · 495 citations · Full text

Medicine, Oncology, Surgery +16

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux et al. · The Lancet Oncology · 2020 · 482 citations · Full text

Medicine, Oncology, Surgery +10